Literature DB >> 21600374

An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

Michelle C Janelsins1, Sadhna Kohli, Supriya G Mohile, Kenneth Usuki, Tim A Ahles, Gary R Morrow.   

Abstract

The purpose of this review is to summarize the current literature on the effects of cancer treatment-related cognitive difficulties, with a focus on the effects of chemotherapy. Numerous patients have cognitive difficulties during and after cancer treatments and, for some, these effects last years after treatment. We do not yet fully understand which factors increase susceptibility to cognitive difficulties during treatment and which cause persistent problems. We review possible contributors, including genetic and biological factors. Mostly we focus is on cognitive effects of adjuvant chemotherapy for breast cancer; however, cognitive effects of chemotherapy on the elderly and brain tumor patients are also discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21600374      PMCID： PMC3120018          DOI： 10.1053/j.seminoncol.2011.03.014

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  78 in total

1.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Karen Skalla; Marie B Whedon; Sarah Bivens; Tara Mitchell; E Robert Greenberg; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

2.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

3.  Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.

Authors:  Arti Hurria; Carol Rosen; Clifford Hudis; Enid Zuckerman; Katherine S Panageas; Mark S Lachs; Matthew Witmer; Wilfred G van Gorp; Monica Fornier; Gabriella D'Andrea; Mark Moasser; Chau Dang; Catherine Van Poznak; Anju Hurria; Jimmie Holland
Journal:  J Am Geriatr Soc       Date:  2006-06       Impact factor: 5.562

4.  Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.

Authors:  Christina A Meyers; Maher Albitar; Elihu Estey
Journal:  Cancer       Date:  2005-08-15       Impact factor: 6.860

5.  Self-reported cognitive impairment in patients with cancer.

Authors:  Sadhna Kohli; Jennifer J Griggs; Joseph A Roscoe; Pascal Jean-Pierre; Christopher Bole; Karen M Mustian; Renae Hill; Kelly Smith; Howard Gross; Gary R Morrow
Journal:  J Oncol Pract       Date:  2007-03       Impact factor: 3.840

6.  Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.

Authors:  Kerstin Hermelink; Michael Untch; Michael P Lux; Rolf Kreienberg; Thomas Beck; Ingo Bauerfeind; Karin Münzel
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

7.  Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.

Authors:  Julia E Heck; Steven M Albert; Rebeca Franco; Sherri Sheinfeld Gorin
Journal:  J Am Geriatr Soc       Date:  2008-08-04       Impact factor: 5.562

Review 8.  Geriatric assessment in older patients with breast cancer.

Authors:  Heidi Klepin; Supriya Mohile; Arti Hurria
Journal:  J Natl Compr Canc Netw       Date:  2009-02       Impact factor: 11.908

9.  Determinants of survival in older cancer patients.

Authors:  J S Goodwin; J M Samet; W C Hunt
Journal:  J Natl Cancer Inst       Date:  1996-08-07       Impact factor: 13.506

10.  Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.

Authors:  Barbara Collins; Joyce Mackenzie; Angela Stewart; Catherine Bielajew; Shailendra Verma
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894
View more
  112 in total

Review 1.  Psychosocial care in cancer.

Authors:  Samantha B Artherholt; Jesse R Fann
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 2.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

3.  Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.

Authors:  Haryana M Dhillon; Ian F Tannock; Gregory R Pond; Corrinne Renton; Sean B Rourke; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2017-10-27       Impact factor: 4.442

4.  The usefulness of sLORETA in evaluating the effect of high-dose ARA-C on brain connectivity in patients with acute myeloid leukemia: an exploratory study.

Authors:  A Zarabla; S Ungania; A Cacciatore; A Maialetti; G Petreri; A Mengarelli; A Spadea; F Marchesi; D Renzi; Svitlana Gumenyuk; L Strigari; Marta Maschio
Journal:  Funct Neurol       Date:  2017 Oct/Dec

Review 5.  Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.

Authors:  Xiao-Min Wang; Brian Walitt; Leorey Saligan; Agnes F Y Tiwari; Chi Wai Cheung; Zhang-Jin Zhang
Journal:  Cytokine       Date:  2015-01-05       Impact factor: 3.861

Review 6.  Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.

Authors:  Jennifer N Vega; Julie Dumas; Paul A Newhouse
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-06       Impact factor: 4.105

7.  Effect of an Internet-based telehealth system on functional capacity and cognition in breast cancer survivors: a secondary analysis of a randomized controlled trial.

Authors:  Noelia Galiano-Castillo; Manuel Arroyo-Morales; Mario Lozano-Lozano; Carolina Fernández-Lao; Lydia Martín-Martín; Rosario Del-Moral-Ávila; Irene Cantarero-Villanueva
Journal:  Support Care Cancer       Date:  2017-06-22       Impact factor: 3.603

Review 8.  Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

Authors:  Karen M Mustian; Calvin L Cole; Po Ju Lin; Matt Asare; Chunkit Fung; Michelle C Janelsins; Charles S Kamen; Luke J Peppone; Allison Magnuson
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

Review 9.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

10.  Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.

Authors:  Shelli R Kesler; Christa Watson; Della Koovakkattu; Clement Lee; Ruth O'Hara; Misty L Mahaffey; Jeffrey S Wefel
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.